Global Information
회사소개 | 문의 | 비교리스트

헬스케어 검사 서비스 시장 규모, 점유율, 전망, 기회 분석(2021-2028년) : 서비스 종류별, 제품 종류별, 개발 단계별, 최종사용자별, 지역별

Healthcare Testing Services Market, by Service Type, by Product Type, by Development Stage, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

리서치사 Coherent Market Insights
발행일 2021년 12월 상품코드 1045560
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,500 ₩ 5,792,000 PDF (Single User License)
US $ 7,000 ₩ 9,011,000 PDF (Multi User License)
US $ 10,000 ₩ 12,873,000 PDF (Enterprise User License)


헬스케어 검사 서비스 시장 규모, 점유율, 전망, 기회 분석(2021-2028년) : 서비스 종류별, 제품 종류별, 개발 단계별, 최종사용자별, 지역별 Healthcare Testing Services Market, by Service Type, by Product Type, by Development Stage, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
발행일 : 2021년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 헬스케어 검사 서비스 시장을 견인하는 주요 요인으로 복잡한 연구개발 절차, 제품 컴플라이언스에 관한 엄격한 정부 규제, 규제 당국에 의한 제품 승인 증가, 새로운 서비스나 제품 발매 등이 있습니다. 또한 신종 코로나바이러스 치료제나 진단 키트를 개발하기 위해서 정부나 연구기관이 제약 기업과 의료기기 제조 기업에 자금을 제공하는 대처 증가, 연구개발 활동 증가, COVID-19의 발생에 의한 임상시험 증가 등이 시장에 유리한 기회를 생성할 것으로 예상됩니다.

세계의 헬스케어 검사 서비스(Healthcare Testing Services) 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인·억제요인 분석, 시장 전망, COVID-19의 영향, 서비스 종류별, 제품 종류별, 개발 단계별, 최종사용자별, 지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등 체계적인 정보를 제공합니다.

목차

제1장 조사 목적과 가정

제2장 시장 전망

  • 보고서 설명
    • 시장 정의와 범위
  • 주요 요약
    • 시장 내역 : 서비스 종류별
    • 시장 내역 : 제품 종류별
    • 시장 내역 : 개발 단계별
    • 시장 내역 : 최종사용자별
    • 시장 내역 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제 및 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • 영향 분석
  • 업계 동향
  • 인수와 협업 시나리오
  • PEST 분석
  • 규제 시나리오
  • 시장 동향

제4장 세계의 헬스케어 검사 서비스 시장 : 코로나바이러스(Covid-19) 팬데믹의 영향

  • 경제적 영향
  • 임상시험과 의약품 개발에 대한 영향
  • 정부 정책

제5장 세계의 헬스케어 검사 서비스 시장 : 서비스 종류별(2021-2028년)

  • 서론
  • 화학 검사
  • 미생물학적 검사
  • 독성 검사
  • 안정성 검사
  • 기타

제6장 세계의 헬스케어 검사 서비스 시장 : 제품 종류별(2021-2028년)

  • 서론
  • 항바이러스제
  • HIV약
  • 배란유발제
  • 항당뇨병제
  • 호흡기용 약
  • 항응고제
  • 의료기기
  • 의약품 포장
  • 기타

제7장 세계의 헬스케어 검사 서비스 시장 : 개발 단계별(2021-2028년)

  • 서론
  • 전임상
  • 임상
  • 제조

제8장 세계의 헬스케어 검사 서비스 시장 : 최종사용자별(2021-2028년)

  • 서론
  • 제약 업계
  • 수탁조사기관
  • 기타

제9장 세계의 헬스케어 검사 서비스 시장 : 지역별(2021-2028년)

  • 서론
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제10장 경쟁 상황

  • 히트맵 분석
  • 시장 점유율 분석
    • Eurofins Scientific
    • PPD, Inc.
    • Microbac Laboratories, Inc.
    • ARL Bio Pharma, Inc.
    • Consumer Product Testing Company, Inc.
    • Element Materials Technology Ltd.
    • Intertek Group plc
    • DYNALABS LLC.
    • ADPEN Laboratories, Inc.
    • Moderna Inc.
    • ZYUS Life Sciences Inc.
    • PCI Pharma Services
    • Perfectus Biomed
    • Alcami Corporation Inc.
    • SGS SA.
    • Predictive Laboratories
    • Lasa Supergenerics Ltd.
    • Roche Diagnostics India
    • National Jewish Health
    • Parexel International Corporation
    • Pfizer Inc.
  • 애널리스트의 견해

제11장 섹션

KSM 22.02.25

Healthcare testing services are invented, and developed in the laboratories. During pharmaceutical production and research and development, healthcare testing in labs is required at practically every stage including preclinical, clinical, and manufacturing. It is used to test raw materials and to perform an in-process quality control (IPQC) of dosage forms and finished products. Healthcare testing aids in assessing a medical product's safety, efficacy, stability, and dosage potency. Before releasing a product in the market, a healthcare testing laboratory can assist in testing to ensure that it is safe to use. Chemical testing, microbiological testing, toxicological testing, stability testing, and other services are just a few services that healthcare testing laboratories offer to guarantee the safety of medications and treatments.

Market Dynamics

Complex research and development procedures, stringent government regulations regarding product compliance, increasing product approvals by regulatory authorities, and launches of novel services and products are the major factors that are expected to drive the growth of the global healthcare testing services market over the forecast period.

Moreover, increasing number of funding initiatives by government and research organizations to provide funding to pharmaceutical and medical device manufacturing companies in order to develop drugs and diagnostic kits for the treatment of novel coronavirus, increasing research and development activities, and rising number of clinical trials owing to the COVID-19 outbreak are expected to create lucrative opportunities in the market. Many research organizations and government agencies are funding pharmaceutical and medical device manufacturing companies for the development of kits for diagnosis and drugs, and for the treatment of the novel coronavirus.

For instance, in April 2020, Moderna Inc., a clinical-stage biotechnology company, received US$ 483 million funding from the U.S. Biomedical Advanced Research and Development Authority (BARDA) for rapid development of Moderna's mRNA vaccine candidate (mRNA-1273) against the SARS-CoV-2 coronavirus. The funding will be through Phase II and III clinical trials to United States Food and Drug Administration (FDA) licensure.

Key features of the study:

  • This report provides an in-depth analysis of the global healthcare testing services market, provides market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global healthcare testing services market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Eurofins Scientific, PPD, Inc., Microbac Laboratories, Inc., ARL Bio Pharma, Inc., Consumer Product Testing Company, Inc., Element Materials Technology Ltd., Intertek Group plc, DYNALABS LLC., ADPEN Laboratories, Inc., Moderna Inc., ZYUS Life Sciences Inc., PCI Pharma Services, Perfectus Biomed, Alcami Corporation Inc., SGS SA, Predictive Laboratories, Lasa Supergenerics Ltd, Roche Diagnostics India, National Jewish Health, and Parexel International Corporation, and Pfizer Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global healthcare testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare testing services market

Detailed Segmentation:

  • Global Healthcare Testing Services Market, By Service Type:
    • Chemical Testing
    • Microbiological Testing
    • Toxicology Testing
    • Stability Testing
    • Others
  • Global Healthcare Testing Services Market, By Product Type:
    • Anti-viral Drugs
    • HIV Drugs
    • Fertility Drugs
    • Anti-diabetic Drugs
    • Respiratory Drugs
    • Anticoagulants
    • Medical Devices
    • Pharmaceutical Packaging
    • Others
  • Global Healthcare Testing Services Market, By Development Stage:
    • Preclinical
    • Clinical
    • Manufacturing
  • Global Healthcare Testing Services Market, By End User:
    • Pharmaceutical Industry
    • Contract Research Organization
    • Others
  • Global Healthcare Testing Services Market, By Region:
    • North America
      • By Service Type
      • Chemical Testing
      • Microbiological Testing
      • Toxicology Testing
      • Stability Testing
      • Others
      • By Product Type
      • Anti-viral Drugs
      • HIV Drugs
      • Fertility Drugs
      • Anti-diabetic Drugs
      • Respiratory Drugs
      • Anticoagulants
      • Medical Devices
      • Pharmaceutical Packaging
      • Others
      • By Development Stage
      • Preclinical
      • Clinical
      • Manufacturing
      • By End User
      • Pharmaceutical Industry
      • Contract Research Organization
      • Others
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Service Type
      • Chemical Testing
      • Microbiological Testing
      • Toxicology Testing
      • Stability Testing
      • Others
      • By Product Type
      • Anti-viral Drugs
      • HIV Drugs
      • Fertility Drugs
      • Anti-diabetic Drugs
      • Respiratory Drugs
      • Anticoagulants
      • Medical Devices
      • Pharmaceutical Packaging
      • Others
      • By Development Stage
      • Preclinical
      • Clinical
      • Manufacturing
      • By End User
      • Pharmaceutical Industry
      • Contract Research Organization
      • Others
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Service Type
      • Chemical Testing
      • Microbiological Testing
      • Toxicology Testing
      • Stability Testing
      • Others
      • By Product Type
      • Anti-viral Drugs
      • HIV Drugs
      • Fertility Drugs
      • Anti-diabetic Drugs
      • Respiratory Drugs
      • Anticoagulants
      • Medical Devices
      • Pharmaceutical Packaging
      • Others
      • By Development Stage
      • Preclinical
      • Clinical
      • Manufacturing
      • By End User
      • Pharmaceutical Industry
      • Contract Research Organization
      • Others
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Service Type
      • Chemical Testing
      • Microbiological Testing
      • Toxicology Testing
      • Stability Testing
      • Others
      • By Product Type
      • Anti-viral Drugs
      • HIV Drugs
      • Fertility Drugs
      • Anti-diabetic Drugs
      • Respiratory Drugs
      • Anticoagulants
      • Medical Devices
      • Pharmaceutical Packaging
      • Others
      • By Development Stage
      • Preclinical
      • Clinical
      • Manufacturing
      • By End User
      • Pharmaceutical Industry
      • Contract Research Organization
      • Others
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Service Type
      • Chemical Testing
      • Microbiological Testing
      • Toxicology Testing
      • Stability Testing
      • Others
      • By Product Type
      • Anti-viral Drugs
      • HIV Drugs
      • Fertility Drugs
      • Anti-diabetic Drugs
      • Respiratory Drugs
      • Anticoagulants
      • Medical Devices
      • Pharmaceutical Packaging
      • Others
      • By Development Stage
      • Preclinical
      • Clinical
      • Manufacturing
      • By End User
      • Pharmaceutical Industry
      • Contract Research Organization
      • Others
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Service Type
      • Chemical Testing
      • Microbiological Testing
      • Toxicology Testing
      • Stability Testing
      • Others
      • By Product Type
      • Anti-viral Drugs
      • HIV Drugs
      • Fertility Drugs
      • Anti-diabetic Drugs
      • Respiratory Drugs
      • Anticoagulants
      • Medical Devices
      • Pharmaceutical Packaging
      • Others
      • By Development Stage
      • Preclinical
      • Clinical
      • Manufacturing
      • By End User
      • Pharmaceutical Industry
      • Contract Research Organization
      • Others
      • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Eurofins Scientific *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • PPD, Inc.
    • Microbac Laboratories, Inc.
    • ARL Bio Pharma, Inc.
    • Consumer Product Testing Company, Inc.
    • Element Materials Technology Ltd.
    • Intertek Group plc
    • DYNALABS LLC.
    • ADPEN Laboratories, Inc.
    • Moderna Inc.
    • ZYUS Life Sciences Inc.
    • PCI Pharma Services
    • Perfectus Biomed
    • Alcami Corporation Inc.
    • SGS SA
    • Predictive Laboratories
    • Lasa Supergenerics Ltd
    • Roche Diagnostics India
    • National Jewish Health
    • Parexel International Corporation
    • Pfizer Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Service Type
    • Market Snippet, By Product Type
    • Market Snippet, By Development Stage
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Industry Trends
  • Acquisition and Collaboration Scenario
  • PEST Analysis
  • Regulatory Scenario
  • Market Trends

4. Global Healthcare Testing Services Market - Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • Impact on Clinical Trials and Drug Development
  • Government Initiatives

5. Global Healthcare Testing Services Market, By Service Type, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Chemical Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Microbiological Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Toxicology Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Stability Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)

6. Global Healthcare Testing Services Market, By Product Type, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Anti-viral Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • HIV Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Fertility Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Anti-diabetic Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Respiratory Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Anticoagulants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Medical Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Pharmaceutical Packaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)

7. Global Healthcare Testing Services Market, By Development Stage, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Preclinical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Clinical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Manufacturing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)

8. Global Healthcare Testing Services Market, By End User, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Pharmaceutical Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Contract Research Organization
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)

9. Global Healthcare Testing Services Market, By Region, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2028
  • North America
    • Market Size and Forecast, By Service Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Development Stage, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn.)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Service Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Development Stage, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn.)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Service Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Development Stage, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn.)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Service Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Development Stage, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn.)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Service Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Development Stage, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn.)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Service Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Development Stage, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn.)
    • Market Size and Forecast, By Region/Country, 2017 - 2028, (US$ Mn.)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Eurofins Scientific
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • PPD, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Microbac Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ARL Bio Pharma, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Consumer Product Testing Company, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Element Materials Technology Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Intertek Group plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • DYNALABS LLC.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ADPEN Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Moderna Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ZYUS Life Sciences Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • PCI Pharma Services
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Perfectus Biomed
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Alcami Corporation Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • SGS SA.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Predictive Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lasa Supergenerics Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Roche Diagnostics India
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • National Jewish Health
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Parexel International Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q